Crosstalk between gut microbiota and gut resident macrophages in inflammatory bowel disease.

IF 4.7 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL Journal of Translational Internal Medicine Pub Date : 2023-12-20 eCollection Date: 2023-12-01 DOI:10.2478/jtim-2023-0123
Haohao Zhang, Xueying Wang, Jing Zhang, Yixuan He, Xiumin Yang, Yongzhan Nie, Lijuan Sun
{"title":"Crosstalk between gut microbiota and gut resident macrophages in inflammatory bowel disease.","authors":"Haohao Zhang, Xueying Wang, Jing Zhang, Yixuan He, Xiumin Yang, Yongzhan Nie, Lijuan Sun","doi":"10.2478/jtim-2023-0123","DOIUrl":null,"url":null,"abstract":"<p><p>Macrophages residing in the gut maintain gut homeostasis by orchestrating patho-gens and innocuous antigens. A disturbance in macrophages leads to gut inflamma-tion, causing conditions such as inflammatory bowel disease (IBD). Macrophages ex-hibit remarkable plasticity, as they are sensitive to various signals in the tissue micro-environment. During the recent decades, gut microbiota has been highlighted refer-ring to their critical roles in immunity response. Microbiome-derived metabolites and products can interact with macrophages to participate in the progression of IBD. In this review, we describe recent findings in this field and provide an overview of the current understanding of microbiota-macrophages interactions in IBD, which may lead to the development of new targets and treatment options for patients with IBD.</p>","PeriodicalId":51339,"journal":{"name":"Journal of Translational Internal Medicine","volume":"11 4","pages":"382-392"},"PeriodicalIF":4.7000,"publicationDate":"2023-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10732497/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Translational Internal Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2478/jtim-2023-0123","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/12/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Macrophages residing in the gut maintain gut homeostasis by orchestrating patho-gens and innocuous antigens. A disturbance in macrophages leads to gut inflamma-tion, causing conditions such as inflammatory bowel disease (IBD). Macrophages ex-hibit remarkable plasticity, as they are sensitive to various signals in the tissue micro-environment. During the recent decades, gut microbiota has been highlighted refer-ring to their critical roles in immunity response. Microbiome-derived metabolites and products can interact with macrophages to participate in the progression of IBD. In this review, we describe recent findings in this field and provide an overview of the current understanding of microbiota-macrophages interactions in IBD, which may lead to the development of new targets and treatment options for patients with IBD.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
炎症性肠病中肠道微生物群与肠道常驻巨噬细胞之间的相互关系
居住在肠道中的巨噬细胞通过协调病原体和无害抗原来维持肠道平衡。巨噬细胞紊乱会导致肠道发炎,引起炎症性肠病(IBD)等疾病。巨噬细胞对组织微环境中的各种信号非常敏感,因此具有显著的可塑性。近几十年来,肠道微生物群因其在免疫反应中的关键作用而备受关注。微生物衍生的代谢物和产物可与巨噬细胞相互作用,参与 IBD 的进展。在这篇综述中,我们描述了这一领域的最新发现,并概述了目前对 IBD 中微生物群与巨噬细胞相互作用的理解,这可能会为 IBD 患者开发出新的靶点和治疗方案。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Translational Internal Medicine
Journal of Translational Internal Medicine MEDICINE, GENERAL & INTERNAL-
CiteScore
5.50
自引率
8.20%
发文量
41
期刊最新文献
Artificial intelligence for disease X: Progress and challenges. Association of life's essential 8 with prevalence and all-cause mortality of chronic kidney disease among US adults: Results from the National Health and Nutrition Examination Survey (2015-2018). Development and validation of web-based risk score predicting prognostic nomograms for elderly patients with primary colorectal lymphoma: A population-based study. Effectiveness and safety of Qixuekang Oral Liquid on vascular health. Gene therapy in polycystic kidney disease: A promising future.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1